Eloy del Potro

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

Albert Oriol, Susana Vives, Jesús María Hernández‐Rivas et al. · Haematologica · 2010 · 292 citations · Full text

Medicine, Oncology, Chemotherapy +14

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

Josep‐María Ribera, Albert Oriol, Miguel Á. Sanz et al. · Journal of Clinical Oncology · 2008 · 261 citations

Medicine, Oncology, Pediatrics +15

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 253 citations · Full text

Medicine, Hematology, Oncology +17

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

Josep‐María Ribera, Albert Oriol, Marcos González et al. · Haematologica · 2009 · 190 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.

Josep‐María Ribera, Albert Oriol, Concepción Bethencourt et al. · PubMed · 2005 · 168 citations

Medicine, Oncology, Cell Therapy +14